In a previous study, treatment with I3C was found to improve cardiac function in a rat myocardial infarction model by reducing the expression of apoptotic markers such as cytochrome C, caspase-9, and caspase-3 (Ramakrishna and Krishnamurthy, 2022). This evidence concerns the gene CASP3 and myocardial infarction.